Médecins pour TEP-IRM à Istanbul, Turquie — Page 2

Dr. Tuncay Tas is a urological surgeon at Safe Urology Clinic in Istanbul. He is one of the first five doctors globally to publish results on P-Shot applications. Dr. Tas specializes in urological oncology and male sexual health. He completed his fellowship at Heidelberg University in Germany. His practice focuses on regenerative medicine and robotic surgery for cancer.

• Developed a surgical technique for penile enhancement with a UK-based certification.
• Introduced combined PRP and stem cell penile injections to Turkey.
• Performs robotic prostatectomies and kidney-sparing surgeries.
• Member of the International Society for Stem Cells Applications.

Dr. Murat Ayhan is an associate professor of medical oncology at Liv Hospital Vadistanbul in Istanbul. He specializes in the treatment of breast, lung, and colorectal cancers. Dr. Ayhan is a prolific researcher with over 30 published scientific articles. He focuses on molecular oncology and targeted drug therapies for metastatic conditions.

• Participates in international clinical trials for novel breast and lung cancer treatments.
• Authored several medical book chapters on targeted agents and oncological emergencies.
• Expert in utilizing FDG PET/CT imaging to predict treatment responses in breast cancer.
• Works at a JCI-accredited hospital recognized for colorectal surgery excellence.

Dr. Senem Karabulut is a medical oncologist at Biruni University Hospital in Istanbul. She is a professor and holds a PhD in molecular oncology. Dr. Karabulut is certified by the European Society for Medical Oncology (ESMO) Board. She previously trained as an observer at University Hospital in New Jersey, USA.

• Specializes in immunotherapy and targeted treatments for gastrointestinal and breast cancers.
• Treats hepatobiliary system tumors, lung cancer, and genitourinary malignancies.
• Qualified by the Turkish Medical Oncology Society Board Exam.
• Practices at Biruni University Hospital, a TEMOS-accredited facility.

Dr. Didem Karacetin is a radiation oncologist at Biruni University Hospital in Istanbul. She completed clinical training at the Princess Margaret Hospital in Toronto. Dr. Karacetin is a former Head of the Department of Radiation Oncology at Health Sciences University. She specializes in intraoperative radiotherapy for breast cancer and brachytherapy for gynecological tumors.

• Holds a Master’s degree in Phytotherapy from Istanbul University.
• Certified in Hydrogel SpaceOAR applications for prostate cancer treatment.
• Treats lung, brain, and gastrointestinal cancers using targeted radiation.
• Practices at Biruni University Hospital, which holds TEMOS and ISO quality certifications.

Dr. Rafet Eren is a hematologist at Biruni University Hospital in Istanbul. He specializes in treating leukemia, lymphoma, and myeloma. Dr. Eren is an Associate Professor with around 50 scientific publications in international journals. He received the Young Researcher Award from the Turkish Society of Hematology.

• Performs bone marrow transplants and haploidentical stem cell transplantation.
• Provides CAR T-cell therapy and biological treatments for blood cancers.
• Member of the European Society of Hematology and the Turkish Hematology Association.
• Works at Biruni University Hospital, a TEMOS-accredited facility in Turkey.

Dr. Emre Merdan Fayda is a radiation oncologist at Liv Hospital Vadistanbul in Turkey. He is a Professor of Medicine with a focus on MR Linac and 4D radiotherapy. Dr. Fayda completed specialized training in thoracic oncology and stereotactic radiotherapy in the USA. He works at a JCI-accredited facility recognized as a Center of Excellence for robotic surgery.

• Specializes in three-dimensional brachytherapy and IMRT for breast and lung cancers.
• Treats complex tumors of the central nervous system, head, neck, and skin.
• Maintains a consulting role for radiation oncology at international medical centers.
• Held academic and clinical leadership positions at Istanbul University Oncology Institution.

Le médecin a mené des recherches significatives sur la dose efficace cumulative de rayonnement des scanners thoraciques chez les patients atteints de COVID-19. Ce travail souligne l'importance de respecter les directives pour minimiser l'exposition inutile, reflétant un engagement envers la sécurité des patients et la pratique fondée sur des preuves.<\/p>